Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing 6-mercaptopurine Therapy in Pediatric ALL Using Allopurinol
NCT03022747Phase 2Unknown
- Sponsor
- Region Västra Götaland
- Start
- Jan 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of allopurinol in acute lymphoblastic leukemia (ALL), sponsored by Region Västra Götaland. Status: unknown.
02
Drugs
allopurinol
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT03022747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03022747.